Trends in net survival for patients with brain tumors in Japan, 2000–14 (CONCORD-3)

Five-year net survival for brain tumors in Japan improved during 2000-2014, with remarkable variations by morphologic type. Survival improved for all age groups, and particularly for younger patients, highlighting the need for enhanced survivorship care. Japan's focus on comprehensive data collection and supportive care for longer-term survivors remains key for further progress. When comparedinternationally, Japan's gains sit at the higher end of reported survival ranges, underscoring how robust registry infrastructure and equitable access to care could inform strategies for brain tumor care.

Authors

Institutions

Publication Details

Journal
Japanese Journal of Clinical Oncology
Published
2025-10-09
DOI
https://doi.org/10.1093/jjco/hyaf165
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trends in net survival for patients with brain tumors in Japan, 2000–14 (CONCORD-3)

Masashi Matsuzaka, Seiki Kanemura, Norihiro Teramoto, Kaname Watanabe et al.
Japanese Journal of Clinical Oncology
Glioma Diagnosis and Treatment
article

Trends in net survival for patients with brain tumors in Japan, 2000–14 (CONCORD-3)

Masashi Matsuzaka, Seiki Kanemura, Norihiro Teramoto, Kaname Watanabe, Isao Miyashiro, Fumitaka Moki, Hidemi Ito, Mari Saito, I. Oze, Marisa Nishio, A. Shibata, V Di Carlo, Laureline Gatellier, Natsumi Yamashita, Y Nemoto, M Matz, K Kurosawa, Hiromi Sugiyama, Claudia Allemani, M. Nicole Coleman, Rina Tanaka, S. Fujita, Kayo Nakata, Yasuharu Kaizaki, Izumi Oki, Hiroto Narimatsu, Daisuke Mori, Tomohiro Matsuda, Isao Yoshida
article en

Abstract

Five-year net survival for brain tumors in Japan improved during 2000-2014, with remarkable variations by morphologic type. Survival improved for all age groups, and particularly for younger patients, highlighting the need for enhanced survivorship care. Japan's focus on comprehensive data collection and supportive care for longer-term survivors remains key for further progress. When comparedinternationally, Japan's gains sit at the higher end of reported survival ranges, underscoring how robust registry infrastructure and equitable access to care could inform strategies for brain tumor care.

Japanese Journal of Clinical OncologyVol. 56(Supplement_1)
University of London (GB), University College London Hospitals NHS Foundation Trust (GB), Hirosaki University (JP), Gunma University (JP), Saitama Prefectural University (JP), Osaka Medical and Pharmaceutical University (JP), Radiation Effects Research Foundation (JP), Kanagawa Prefectural Hospital Organization (JP), Fukui Prefectural Hospital (JP), National Cancer Center (US), London School of Hygiene & Tropical Medicine (GB), Osaka International Cancer Institute (JP), Saga-Ken Medical Centre Koseikan (JP), Miyagi Prefectural Hospital Organization (JP), Prevention Group (US), Yamagata Prefectural Central Hospital (JP), Tochigi Cancer Center (JP), Aichi Cancer Center (JP), Ibaraki Prefectural Police (JP), Shikoku Cancer Center (JP), Hirosaki University Hospital (JP), University College London (GB), National Cancer Research Institute (GB), Osaka University of Pharmaceutical Sciences (JP)
Industry, innovation and infrastructure
Openalex Percentile: Top 22%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.